ID: ALA5278607

Max Phase: Preclinical

Molecular Formula: C38H35N5O5S

Molecular Weight: 673.80

Associated Items:

Representations

Canonical SMILES:  Cc1ccc(C2=NN(c3ccccc3)C(=O)C23N=C([S@@+](C)[O-])N(C(=O)OC(C)(C)C)[C@]32C(=O)N(Cc3ccccc3)c3ccccc32)cc1

Standard InChI:  InChI=1S/C38H35N5O5S/c1-25-20-22-27(23-21-25)31-37(32(44)43(40-31)28-16-10-7-11-17-28)38(42(34(39-37)49(5)47)35(46)48-36(2,3)4)29-18-12-13-19-30(29)41(33(38)45)24-26-14-8-6-9-15-26/h6-23H,24H2,1-5H3/t37?,38-,49-/m1/s1

Standard InChI Key:  DRNNZACIBKLUGB-DXSJNJSVSA-N

Associated Targets(Human)

Acyl coenzyme A:cholesterol acyltransferase 1029 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 673.80Molecular Weight (Monoisotopic): 673.2359AlogP: 5.91#Rotatable Bonds: 4
Polar Surface Area: 117.94Molecular Species: NEUTRALHBA: 7HBD: 0
#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 0#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: CX LogP: 6.31CX LogD: 6.31
Aromatic Rings: 4Heavy Atoms: 49QED Weighted: 0.25Np Likeness Score: -0.61

References

1. Zhao Z, Dai X, Li C, Wang X, Tian J, Feng Y, Xie J, Ma C, Nie Z, Fan P, Qian M, He X, Wu S, Zhang Y, Zheng X..  (2020)  Pyrazolone structural motif in medicinal chemistry: Retrospect and prospect.,  186  [PMID:31761383] [10.1016/j.ejmech.2019.111893]

Source